Al-Majali Ibrahim Salameh, Al-Oran Sawsan Atallah, Hassuneh Mona Rushdie, Al-Qaralleh Haitham Naief, Rayyan Walid Abu, Al-Thunibat Osama Yosef, Mallah Eyad, Abu-Rayyan Ahmed, Salem Shadi
Al-Ghad International College for Applied Medical Sciences, Tabuk, Saudi Arabia.
Biology Department, University of Jordan, Amman, Jordan.
Cent Eur J Immunol. 2017;42(3):231-238. doi: 10.5114/ceji.2017.70964. Epub 2017 Oct 30.
This study was conducted to assess the in vivo and ex vivo immunomodulatory effect of the ethanol leaves extract of Moringa peregrina in Balb/c mice. For this study, five groups of 5 Balb/c mice were given a single acute subtoxic oral dose of the ethanolic extract at 1.13, 11.30, 23.40 and 113.4 mg/kg and the immunomodulatory effect was assessed on the 6 day following the ingestion. In the (non-functional) assessment, the effect of the extract on the body weight, relative lymphoid organ weight, splenic cellularity and peripheral blood hematologic parameters were evaluated. While in the immunomodulation assessment (functional), we investigated the effect of the extract on the proliferative capacity of splenic lymphocytes and peripheral T and B lymphocytes using mitogen blastogenesis, mixed allogeneic MLR and IgM-Plaque forming cells assays. The ingestion of M. peregrina extract caused a significant increase in the body weight, weight and number of cells of spleen and lymph nodes of the treated mice. Furthermore, the count of RBCs, WBCs, platelets, hemoglobin concentration and PCV % were increased by the extract treatment in a dose-dependent manner. M. peregrina enhanced the proliferative responses of splenic lymphocytes for both T cell and B-cell mitogens. Likewise, the mixed lymphocyte reaction MLR assay has revealed a T-cell dependent proliferation enhancement in the extract treated mice. Moreover, the oral administration of M. peregrina leaves extracts significantly increased PFCs/10 splenocytes in a dose-dependent manner. In conclusion, subtoxic acute doses of M. peregrina extract demonstrated significant potential as an immunomodulatory agent even at the lowest dose of 1.13 mg/kg.
本研究旨在评估印度辣木乙醇叶提取物对Balb/c小鼠的体内和体外免疫调节作用。在本研究中,将五组每组5只Balb/c小鼠以1.13、11.30、23.40和113.4 mg/kg的剂量单次急性给予亚毒性口服乙醇提取物,并在摄入后的第6天评估免疫调节作用。在(非功能性)评估中,评估提取物对体重、相对淋巴器官重量、脾细胞数量和外周血血液学参数的影响。而在免疫调节评估(功能性)中,我们使用丝裂原细胞增殖、混合异体MLR和IgM-斑块形成细胞试验研究提取物对脾淋巴细胞以及外周T和B淋巴细胞增殖能力的影响。摄入印度辣木叶提取物导致处理过的小鼠体重、脾脏和淋巴结的重量及细胞数量显著增加。此外,提取物处理以剂量依赖性方式增加了红细胞、白细胞、血小板计数、血红蛋白浓度和红细胞压积百分比。印度辣木增强了脾淋巴细胞对T细胞和B细胞丝裂原的增殖反应。同样,混合淋巴细胞反应MLR试验显示提取物处理的小鼠中T细胞依赖性增殖增强。此外,口服印度辣木叶提取物以剂量依赖性方式显著增加了每10个脾细胞中的PFCs。总之,即使在最低剂量1.13 mg/kg时,亚毒性急性剂量的印度辣木提取物也显示出作为免疫调节剂的显著潜力。